• Antimicrobial Resistance
• Cancer

• Recombinant DNA Technology
• Nuclear Medicine
• Molecular Biology and Genetics
• Biophysics
• Instrumentation

• RP. Pandey, A.Priyadarshini, A. Gupta, A. Vibhuti, E. Leal, et al.,” Exploring the Modulation of Immune Response and Oxidative Stress of Intracellular Pathogens Using Nanoparticles Encapsulating Drugs,” DOI: 10.20944/preprints202010.0580.v1 2020.
• M K. Yadav, A. Vibhuti, A. Priyadarshini, A. Gupta, V. Samuel Raj, and R P. Pandey, “Outbreak of strains of SARS CoV-2, its prevalence & preventive measures taken by different Countries,” DOI: 10.31219/osf.io/ce6vf 2020.
• A. Gupta, A. Priyadarshini, M K. Yadav, A. Vibhuti, V S. Raj, and R P. Pandey ,” Differential behavior of COVID-19 in Multi-Country Journey: Challenges for Drug Intervention,       DOI: 10.31219/osf.io/gtn34 2021.
• Protective Immunity against COVID-19. A. Priyadarshini, A. Gupta, M K.Yadav, A. Vibhuti, R P. Pandey, VS. Raj (Under Review).
• A. Priyadarshini, A. Chakraborti, SK. Singh, “Asp299Gly and Thr399Ile polymorphism of TLR-4 gene in patients with prostate cancer from North India,” Indian J of Urology, Issue 1 Vol. 29, 37-41, 2013.
• A.Priyadarshini and A. Chakraborti, “TLR-4: an inflammatory link to prostate cancer,” International J of Molecular Biology, 2015.

Projects

1. Received financial assistance DSIR- Year 2023
   Title of Project: A study report on research on indigenous development membranes for hospital waste water treatment in India to promote its recycle and reuse
   
   
2. Received financial assistance SRM University, Delhi-NCR, Rajiv Gandhi Education City Sonepat - 131 029, Haryana, India Year 2023
   Title of Project: “Probiotic for AMR Mitigation”
   
   
3. Received financial assistance from SRM University, Delhi-NCR, Rajiv Gandhi Education City Sonepat - 131 029, Haryana, India Year 2023
   Title of Project: “Biovitamins from Sugarcane”.
   
   
4. Received a research Grant from ICMR/DHR (year 2020-2022)
   Title of Project: “Management of multidrug resistant (MDR) pathogens causing  Urinary Tract Infection (UTI)”
   
   
5. Received a research Grant from ICMR/DHR (year 2022-2024)
   Title of Project: “Repurposing of drugs and nanoparticle approaches for the improvement of treatment against Visceral Leishmaniasis with the aim of averting the emergence of PKDL”